THE USE OF KOJIC, TRANEXAMIC AND MANDELIC ACID IN THE TREATMENT OF MELASMA

Abstract

Melasma is a hyperchromia, caused by increased melanin in the skin, causing dark spots located preferably on the face. This pathology can be acquired through unprotected exposure to sunlight, hormonal factors, use of steroid cosmetics, photosensitizers, among others. Its diagnosis is essentially clinical, with prevalence in both genders, and preferably in women between 30 and 55 years. The objective of melasma treatment is to control the disease, such as the significant reduction of spots. In the present work, the use of kojic, tranexamic and mandelic acids as whitening agents to control facial hyperpigmentation will be discussed.